Table 1 Baseline characteristics and surgery-related factors according to preoperative CRP concentrations.
Characteristics | Total analysis sample N = 697 | CRP ≥ 10 mg/L n = 149 | CRP < 10 mg/L n = 548 | p-valuea |
|---|---|---|---|---|
Male, n (%) | 402 (57.7) | 73 (49.0) | 329 (60.0) | 0.02 |
Age, years, mean ± SD | 72.3 ± 5.0 | 72.6 ± 5.1 | 72.2 ± 4.9 | 0.32 |
Study center | 0.22 | |||
Utrecht, n (%) | 152 (21.8) | 27 (18.1) | 125 (22.8) | |
Berlin, n (%) | 545 (78.2) | 122 (81.9) | 423 (77.2) | |
Surgery | 0.04 | |||
Intracranial, n (%) | 9 (1.3) | 1 (0.7) | 8 (1.5) | |
Thoracic/abdominal/pelvic, n (%) | 306 (43.9) | 79 (53.0) | 227 (41.4) | |
Peripheral, n (%) | 382 (54.8) | 69 (46.3) | 313 (57.1) | |
Duration of anaesthesia (min), median (interquartile range) | 201 (121, 310) | 233 (160–397) | 186 (144–289) | < 0.001 |
Depression (GDS ≥ 5), n (%) | 62 (8.9) | 16 (10.7) | 46 (8.4) | 0.37 |
Present or past history of tumour, leukemia or lymphomab, n (%) | 229 (34.7) | 72 (51.1) | 160 (30.8) | < 0.001 |
History of coronary artery disease, n (%) | 131 (18.8) | 33 (22.1) | 98 (17.9) | 0.24 |
History of stroke, n (%) | 35 (5.0) | 9 (6.0) | 26 (4.7) | 0.52 |
History of transient ischemic attack, n (%) | 20 (4.2) | 8 (5.4) | 21 (3.8) | 0.41 |
History of diabetes, n (%) | 159 (22.8) | 46 (30.9) | 113 (20.6) | 0.008 |
History of hypertension, n (%) | 437 (62.7) | 103 (69.1) | 334 (60.9) | 0.07 |
Body mass index (BMI; kg/m2), mean ± SD | 27.2 ± 4.7 | 28.1 ± 6.1 | 26.9 ± 4.2 | 0.03 |
Antibacterial medicationc, n (%) | 18 (2.8) | 9 (6.5) | 9 (1.8) | 0.003 |
NSAIDsc, n (%) | 76 (12.0) | 12 (8.7) | 64 (12.9) | 0.17 |
Steroidsc, n (%) | 36 (5.7) | 11 (7.9) | 25 (5.1) | 0.20 |
Not Fasting, n (%) | 9 (1.3) | 3 (2.0) | 6 (1.1) | 0.38 |
MMSE, median (interquartile range) | 29 (28, 30) | 29 (28–30) | 29 (28–30) | 0.60 |
Pre-morbid IQ, mean ± SD | 112.1 ± 14.5 | 111.6 ± 12.3 | 112.0 ± 13.4 | 0.70 |
S100A12 (ng/mL), median (interquartile range) | 108.2 (64.2–203.7) | 196.2 (98.6–346.1) | 95.3 (58.7–170.5) | < 0.001 |
CRP (mg/L), median (interquartile range) | 3.5 (1.4–8.4) | 19.7 (13.1–36.3) | 2.4 (1.1–5.0) | < 0.001 |
IL-6 (pg/mL), median (interquartile range) | 2.0 (0.4–5.1) | 7.4 (3.2–16.0) | 1.5 (0.4–3.4) | < 0.001 |
IL-18 (pg/mL), median (interquartile range) | 36.4 (26.2–50.4) | 42.2 (29.7–57.7) | 35.6 (25.7–49.1) | 0.001 |